Insulin therapy after revascularizaton raises heart risks in diabetes patients

11/6/2013 |

Diabetes patients who received insulin therapy after undergoing revascularization were more likely to suffer a major heart event such as a heart attack or stroke than those who did not receive insulin. The likelihood of experiencing a major heart event was greater in those who had percutaneous coronary intervention using drug-eluting stents than those who had coronary artery bypass graft surgery. The study was presented at the Transcatheter Cardiovascular Therapeutics meeting.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX